Silexion Therapeutics Receives Approval from Germany’s
CTA Approval from Germany’s Federal Institute for Drugs and Medical Devices (BfArM), accompanied by a positive opinion from…
Bayer, Iambic partner on AI drug discovery
Key Terms
small molecule
medical
A small molecule…
Bayer buys Perfuse in $2.4B deal for ph. 2 eye disease prospect
Bayer has struck a deal to buy Perfuse Therapeutics for $300 million upfront. The buyout, which includes up to…
Bayer scraps ph.1-stage hypertension, neuropathic pain drugs
Bayer has removed a protein therapeutic for hypertension and a treatment for diabetic neuropathic pain from its phase…